World CNS Series’ Post

Complex #CNS challenges? We’ve got you covered. Discover CenExel, a leading #neuroscience clinical research site network with the expertise and track record to help you get more value from your asset.  Learn how now: https://lnkd.in/etsZeuG #ClinicalTrials #PatientRecruitment #Innovation #CenExel

Breakthrough science needs powerful tools. We are empowering researchers to focus on what truly matters—unlocking the mechanisms of disease and advancing drug discovery. Our human iPSC-derived cells are delivered cryopreserved and are ready within days, cutting down months of optimisation time, giving scientists a head-start on their research. Accelerate your research with ioCells > https://hubs.ly/Q02N93kv0 #iPSC #neuroscience #CNSResearch #neurodegeneration #DrugDiscovery #ioCells #optiox, Deepak P. Srivastava, King's College London

MediBrite – High data quality for reliable and save clinical measurements Achieving high and reliable data quality is crucial in clinical research. For this reason, the MediBrite comes with superior features - such as multi-power gain control, ambient light protection, or short separation channels - which do not affect its ease of use. This allows clinicians to record highest quality data within a few minutes, achieving minimum setup time. See how the MediBrite can give you reliable clinical measurements here 🔗 https://lnkd.in/g9MN4-2J #fnirs #clinicalresearch #neuroscience

🚀 Advancing Parkinson’s Disease Research with AnzuBridge 🚀 We’re excited to share our latest video showcasing the transformative potential of AnzuBridge’s media capture and review technology in Parkinson’s disease clinical trials. With precise motor function assessments and real-time analysis, this technology streamlines the process, reducing errors and accelerating trial timelines. For the scientific community, this is a game-changer in improving data accuracy and expediting research. 🧬 Watch the video to learn more! 🔬 Book a FREE demo and see the impact firsthand. #ParkinsonsResearch #ClinicalTrials #AnzuBridge #Neuroscience #ScientificInnovation #DataAccuracy

Neuroscience is undergoing a major resurgence. After more than a decade of limited successes and cautious investment by most big pharma, a new era of innovation is unfolding. Driven by a confluence of factors – the vast unmet need (a 2021 Lancet Neurology study found 3.4 billion people worldwide suffer from nervous system disorders), and the dedication of patients, scientists, physicians, regulators, and companies have continued to de-risk the space with continued innovation on multiple fronts. We explore the latest advancements poised to reshape the future of neurosciences 2024 and beyond.  Check out the link in the comments to read the full paper written by me and my colleague, Bobby Moy at Lumanity. #neuroscience #innovation #biotech #strategy

AnzuBridge’s media capture and review technology has the potential to greatly improve Parkinson's disease clinical trials. By offering accurate motor function assessments and real-time analysis, it helps simplify the process, reducing mistakes and speeding up trial completion. For researchers, this technology is a major improvement, helping to increase data accuracy and move research along faster. #ParkinsonsResearch #ClinicalTrials #InnovationInHealthcare #DataAccuracy #AnzuBridge #HealthcareInnovation #ResearchBreakthrough #FasterTrials #TechForGood

NEW DATA ALERT! In collaboration with Inventia Life Science, bit.bio's ioGlutamatergic Neurons were used to develop 3D neuronal microtissues, addressing the need for more physiologically relevant models for high-throughput drug screening. By combining these neurons with iPSC-derived astrocytes using the RASTRUM™ 3D cell culture platform, mature neuronal tissues with characteristic neurite outgrowths were formed. Scalable to 96- and 384-well plates, this system provides consistent, reproducible 3D models, enabling drug discovery to more closely mimic human tissue behaviour—bringing world-class research directly into the lab. Access the full application note here: https://hubs.ly/Q02TYTqn0 #Neuroscience #iPSCs #3DCellCulture #DrugDiscovery #NeuronalModels #Inventia #optiox #ioCells #sartorius

Today, let's take a look at the market dynamics of the Neurotechnology sector. The prevailing demand for innovative solutions to neurological diseases is the key driver for funding in this sector. Both private and public sectors are responding to this demand, forecasting a 100% market value increase over the next decade. This growth trajectory is set to accelerate with cutting-edge device and technology advancements. And Avery Fairbank will continue to lead the way, providing ongoing insights throughout the year. 🔜 Next week, we will delve into the challenges that shaped the #AdvancedTechnology industry last year and anticipate emerging trends for the future. All insights are drawn from our latest 2023 Advanced Technology Market Analysis Report. Details to download the report can be found in the comment section. Scan the QR code on the last page of this mini-report to connect with us and navigate the dynamic #AdvancedTech space more effectively using these insights. #Neurotechnology #Neuroscience #MarketDynamics

🔊 New Blog Post 🔊 When we embarked on this rare journey, we knew that we must think big. In the early days of Raphael’s diagnosis, Ella Gordon and I understood two important things: 1.💡 Finding a cure for #stxbp1 is a complex project that requires proper management and hands-on involvement. 2.💡 We are not researchers, and lack lots of knowledge and expertise. We need someone to fill that role full-time. This led us to another quest to find Rafa's Moonshot scientific lead. Hiring a Scientific Director is a huge milestone toward success and a cure. 🚀 🌕 Welcome Hila Ben-Moshe :)

𝐁𝐢𝐨𝐠𝐞𝐧 𝐭𝐨 𝐏𝐫𝐞𝐬𝐞𝐧𝐭 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐃𝐚𝐭𝐚 𝐚𝐭 𝐂𝐓𝐀𝐃 𝟐𝟎𝟐𝟒 Biogen will share new insights on Alzheimer’s treatment at the CTAD 2024 Conference in Madrid, 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟗 - 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟏. Join to learn about advancements like LEQEMBI® (lecanemab) and the role of AI in precision medicine. Explore our commitment to supporting Alzheimer’s research through innovative data on preclinical AD, race, and APOE Ɛ4 carrier impacts. https://lnkd.in/ghx8pyeV #biogen #alzheimersdisease #alzheimersresearch #neuroscience #healthcareinnovation #clinicaltrials #AIinmedicine #dementiacare #healthcare #alzheimerstreatment #precisionmedicine #biotech #research